Commit To Purchase Stoke Therapeutics At $12.50, Earn 27.6% Annualized Using Options
August 09, 2024 at 11:33 AM EDT
Investors considering a purchase of Stoke Therapeutics Inc (STOK) stock, but tentative about paying the going market price of $14.22/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2025 put at the $12.50 strike, which has a bid at the time of this writing of $1.85..